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Abstract
Background: Although a variety of animals have been used to produce polyclonal antibodies against antigens, the
production of antigen-specific monoclonal antibodies from animals remains challenging.
Results: We propose a simple and rapid strategy to produce monoclonal antibodies from a variety of animals. By
staining lymph node cells with an antibody against immunoglobulin and a fluorescent dye specific for the
endoplasmic reticulum, plasma/plasmablast cells were identified without using a series of antibodies against
lineage markers. By using a fluorescently labeled antigen as a tag for a complementary cell surface
immunoglobulin, antigen-specific plasma/plasmablast cells were sorted from the rest of the cell population by
fluorescence-activated cell sorting. Amplification of cognate pairs of immunoglobulin heavy and light chain genes
followed by DNA transfection into 293FT cells resulted in the highly efficient production of antigen-specific
monoclonal antibodies from a variety of immunized animals.
Conclusions: Our technology eliminates the need for both cell propagation and screening processes, offering a
significant advantage over hybridoma and display strategies.
Keywords: antigen-specific monoclonal antibody, ER-tracker, ERIAA, FACS, guinea pig, human, MAGrahd, rabbit, rat,
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Background
The mouse hybridoma method has been used previously
for the production of candidate monoclonal antibodies
(mAbs) for therapeutic use [1]. However, immune
responses against highly conserved human proteins are
often weak in mice, resulting in the production of low affi-
nity and/or non-specific mAbs. To avoid the problem of
human proteins being recognized as self-antigens in mice,
the use of an evolutionarily distant animal from humans is
essential to obtain better immunization against therapeutic
target molecules. While a variety of animals have been
used to produce polyclonal antibodies against human pro-
teins, mAbs from animals other than rodents have not
been routinely produced due to the difficulties in estab-
lishing immortalized antibody-producing cell lines by
hybridoma, viral transformation or reprogramming [1-3].
Recently, the direct molecular cloning of cognate pairs of
immunoglobulin gamma heavy chain (IgH) variable (VH),
light chain kappa variable (VL) and light chain lambda
variable (VLl) genes from single antigen-specific plasma/
plasmablast cells (ASPCs) using the polymerase chain
reaction (PCR) has attracted attention as an alternative
method for generating mAbs from immunized animals
[4-7]. Although the use of ASPCs is best suited to the iso-
lation of high affinity mAbs, since they go through the
processes of somatic hypermutation and affinity matura-
tion, the application of this method for species other than
humans and mice is limited because the current plasma/
plasmablast cell (PC) isolation protocols rely on a small
number of identified PC-specific markers combined with
the absence of one or more B cell differentiation antigens
[8]. Furthermore, expensive equipment and acquired tech-
nical skills are required to identify and isolate ASPCs from
the bulk of the PC population [5]. The manual VH and VL
gene amplification from single cells followed by the con-
struction of IgH and immunoglobulin light chain (IgL)
gene expression plasmids are also limiting steps of this
method [4,9-12]. To achieve rapid and scalable automation
for the generation of mAbs from a large numbers of single
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cells, we previously proposed a high-throughput single-
cell-based immunoglobulin gene cloning method by devel-
oping a non-contact magnetic power transmission system
(MAGrahd) for single-cell-based cDNA synthesis and a
target-selective joint PCR (TS-jPCR) for IgH and IgL gene
expression [13,14].
Although fluorescence-activated cell sorting (FACS) has
been used to enrich for particular cell types, there is no
single method to achieve a high yield of isolated ASPCs
with high purity [15-18]. The main limitation with FACS
has been the use of multiple antibodies against lineage-
specific markers to enrich for PCs, causing cell membrane
damage that produces background noise when identifying
ASPCs with fluorescently labeled antigens. In this paper,
we develop a new antigen-specific PC screening method,
termed endoplasmic reticulum (ER)-based identification of
antigen-specific antibody-producing cells (ERIAA), using
FACS and a fluorescent dye specific for the endoplasmic
reticulum. By combining ERIAA and our previously
proposed high-throughput single-cell-based Ig gene
cloning method, we have created a 1-week protocol for
the production of recombinant mAbs from a variety of
immunized animals (Figure 1).
Results
PC identification without using antibodies against lineage
markers
PCs contain abundant ER, reflecting the commitment to
producing large amounts of secreted antibodies. Thus, we
hypothesized that a fluorescent dye specific for the ER
could be used to identify PCs. Lymph node cells from egg
albumin-immunized mice were stained with ER-Tracker™
Blue-White DPX dye (Life Technologies (http://www.life-
technologies.com/), hereafter referred to as ER-tracker)
and anti-mouse IgG Dylight 488 (Abcam (http://www.
abcam.com/)) to identify cells with intense cytoplasmic
ER-derived fluorescence and weak cell surface IgG expres-
sion (Figure 2A). FACS analysis of the lymphocytes (R1
gate) with anti-mouse IgG Dylight 488 and ER-tracker,
combined with anti-CD38-APC and CD45R-PE, revealed
that 79.3% of the IgGlow ERhigh cells (R2 gate) were found
in the PC fraction, which is characterized as being
CD138high CD45Rlow (Figure 2B). R2-gated cells were
analyzed for their expression of cytoplasmic IgG by their
morphologic appearance, which was examined by immu-
nofluorescence staining after FACS sorting. An intense
cytoplasmic IgG signal was found in 82% of the R2-gated
cells, representing a 68-fold enrichment of PCs compared
with the original lymphocyte populations (R1 gate); how-
ever, the IgGlow ERlow cells (R3 gate) contained only 0.4%
PCs (Figure 2C). Using this procedure, we also tried to iso-
late human PCs from the lymph nodes of cancer patients
(Figure 3). FACS analysis of the lymphocytes (R1 gate)
with anti-human IgG Dylight 488 and ER-tracker
combined with anti-CD38-APC and CD20-PE revealed
that 75.7% of the IgGlow ERhigh cells (R2 gate) were found
in the PC fraction. After R2-gated cells were sorted by
FACS, their capacity to express abundant cytoplasmic IgG
was examined by immunofluorescence staining. An
intense cytoplasmic IgG signal was found in 70% to 90%
of the R2-gated cells, which represented a 143-fold to 223-
fold enrichment of PCs compared with the original lym-
phocyte population (R1 gate) containing only 0.4% to 0.5%
PCs. The percentage of PCs identified by IgGlow ERhigh
(0.2%) in R2 gate is not compatible to that identified by
lineage markers (2.7%). Given that the percentage of PCs
determined by immunofluorescence staining of cytosolic
IgG was only 0.4% to 0.5%, PC separation with surface IgG
and ER-tracker is more specific than that with two lineage
markers. Rapid amplification of 5’ cDNA ends PCR (5’
RACE PCR) of the single-cell-sorted R2-gated cells
resulted in the amplification of cognate pairs of VH, VL
and/or VLl genes, with a success ratio of 71% to 77%.
These results clearly indicate that PCs can be isolated
without using antibodies against lineage markers.
Isolation of ASPCs by FACS
The advantage of using the ER-tracker is that a series of
antibodies against lineage markers is not required for
PC identification. Therefore, this procedure enables PC
isolation from a variety of animals and can also dramati-
cally reduce cell damage, which in turn will decrease the
non-specific binding of labeled antigens to the cell sur-
face. Thus, we next attempted to isolate ASPCs using a
fluorescently labeled antigen as a tag for a complemen-
tary cell surface IgG and to sort the cells from the rest
of the cell population using FACS. Green fluorescent
protein (GFP) was selected as a model foreign antigen
against immunized rabbits, which were chosen for their
robust immune system compared to mice and other
rodents. FACS analysis of the lymphocytes of the GFP-
immunized rabbits (R1 gate) with anti-rabbit IgG
Dylight 650 (Abcam), ER-tracker and GFP Dylight 488
revealed the presence of a PC fraction (defined as IgGlow
ERhigh) (R2 gate). The cells in the R2 gate were further
subdivided into fractions according to their binding
levels of GFP to define the ASPCs (IgGlow ERhigh GFP+,
R3 gate) and non-specific PCs (IgGlow ERhigh GFP-, R4
gate) (Figure 4A). We expected the R3-gated cells to
contain GFP-specific IgG in the cytoplasm. To test this
hypothesis, the cells in the R3 and R4 gates were sorted
and examined for expression of an IgG specific for GFP
by immunofluorescence staining. In all, 76% of R3-gated
cells were found to express an IgG specific for GFP,
which was a 252-fold enrichment of ASPCs compared
to the original lymphocyte population (R1 gate).
Although 78% of the IgGlow ERhigh GFP- cells (R4 gate)
expressed an intense cytoplasmic IgG signal, only 11%
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of the cells reacted with GFP (Figure 4B). A single-cell-
based 5’ RACE PCR of the R3-gated and R4-gated cells
resulted in the amplification of cognate pairs of VH and
VL genes, with an overall success rate of 81% and 79%,
respectively (Figure 4C). When pairs of linear IgH and IgL
genes were prepared from each pair of VH and VL genes
by TS-jPCR and transfected into 293FT cells, mAbs
specific for GFP were produced with a high efficiency
from the R3-gated cells (Figure 4D). To determine if this
FACS-based screening method, termed ERIAA, can be
applied to other animals, we also evaluated ASPC isolation
using GFP-immunized rats (Figure 5). FACS analysis of
the rat lymphocytes showed the presence of PC cells (R2
gate), and the R2-gated cells were further classified based
Figure 1 Flowchart summarizing the generation of antigen-specific monoclonal antibodies (mAbs) from a variety of animals. (A)
Fluorescence-activated cell sorting (FACS)-based antigen-specific plasma/plasmablast cell (ASPC) isolation from a variety of animals. Lymphocytes
were stained with fluorescently labeled antibodies against IgG, ER-tracker and fluorescently labeled antigen. ASPCs defined as IgGlow
endoplasmic reticulum (ER)high antigen+ were single-cell sorted into individual wells of 96-well plates. (B) Amplification of cognate pairs of VH
and VL genes from single-cell-sorted ASPCs. Preparation of 3’-end homopolymer-tailed cDNA from single-cell-sorted ASPCs was performed
automatically by MAGrahd. Cognate pairs of VH and VL genes were amplified by 5’ rapid amplification of cDNA ends (RACE) polymerase chain
reaction (PCR). (C) Expression of recombinant mAbs. The amplified VH and VL genes were selectively assembled with IgH and IgL DNA cassettes
by target-selective joint PCR (TS-jPCR) to generate linear IgH and IgL genes. The pairs of IgH and IgL genes were cotransfected into 293FT cells
grown in 96-well culture dishes.
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Figure 2 Identification of mouse plasma/plasmablast cells (PCs) with a fluorescent dye specific for the endoplasmic reticulum (ER). (A)
Cytology images of mouse lymph node cells stained with anti-mouse IgG (green) and ER-tracker (blue). The arrow indicates the IgGlow ERhigh
cells. (B) A representative fluorescence-activated cell sorting (FACS) graph of cells prepared from the lymph nodes of egg albumin-immunized
mice. The forward-versus-side-scatter (FSC vs SSC) with gate R1 represents lymphocytes. The R1-gated cells were stained with anti-mouse IgG
Dylight 488 and ER-tracker, and the IgGlow ERhigh cells (R2) were further analyzed for CD38-APC versus CD45R-PE surface expression using FACS.
The relative number of cells in each region is given as a mean percentage of three separate experiments. (C) FACS-sorted R1-gated, R2-gated
and R3-gated cells stained intracellularly with anti-mouse IgG Dylight 488 (green) and 4’,6-diamidino-2-phenylindole (DAPI; blue). The numbers
indicate the mean percentages of the cells with intense cytoplasmic IgG from three separate experiments.
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Figure 3 Human plasma/plasmablast cell (PC) isolation by fluorescence-activated cell sorting (FACS) using ER-tracker and anti-human
IgG. (A) A representative FACS graph of cells prepared from the lymph nodes of cancer patients. Cells were stained with anti-human IgG
Dylight 488 and ER-tracker, and the IgGlow endoplasmic reticulum (ER)high cells were further analyzed for CD38-APC versus CD20-PE surface
expression using FACS. The forward-versus-side-scatter (FSC vs SSC) with gate R1 represents lymphocytes. PCs are defined herein as CD38high
CD20low cells. A representative FACS graph of three separate experiments is shown. The relative number of cells in each region is given as a
mean percentage of three separate experiments. (B) R1-gated and R2-gated cells stained intracellularly with anti-human IgG Dylight 488 (green).
Nuclei are stained with 4’,6-diamidino-2-phenylindole (DAPI; blue). The numbers indicate the percentages of cells with intense cytoplasmic IgG.
(C) Representative agarose gel electrophoresis of cognate pairs of V genes amplified from single-cell-sorted R3-gated cells. (D) Polymerase chain
reaction (PCR) success ratio for V genes from single-cell-sorted R3-gated cells from lymph nodes of patients with colon and gallbladder cancers.
Kurosawa et al. BMC Biology 2012, 10:80
http://www.biomedcentral.com/1741-7007/10/80
Page 5 of 14
Figure 4 Isolation of rabbit antigen-specific plasma/plasmablast cells (ASPCs) using fluorescence-activated cell sorting (FACS). (A) A
representative FACS graph of the lymphocytes of green fluorescent protein (GFP)-immunized rabbits stained with anti-rabbit IgG Dylight 650,
ER-tracker and GFP Dylight 488. The forward-versus-side-scatter (FSC vs SSC) with gate R1 represents lymphocytes. Plasma/plasmablast cells (PCs)
were gated as IgGlow endoplasmic reticulum (ER)high (R2). The R2-gated cells were further subdivided into the ASPCs (IgGlow ERhigh GFP+, R3
gate) and non-specific PCs (IgGlow ERhigh GFP-, R4 gate). The numbers indicate the mean percentages of cells in the gated area from three
separate experiments. (B) R1-gated, R2-gated, R3-gated and R4-gated cells stained intracellularly with anti-rabbit IgG Dylight 594 (red) and GFP-
Dylight 488 (green). The numbers indicate the mean percentages of cells exhibiting IgG and GFP signals from two separate experiments. (C) A
representative agarose gel electrophoresis of cognate pairs of V genes amplified from single-cell-sorted R3-gated and R4-gated cells (upper).
Polymerase chain reaction (PCR) success ratio for V genes from single-cell-sorted R3-gated and R4-gated cells (lower). (D) The antigen specificity
of rabbit monoclonal antibodies (mAbs) produced from R3-gated and R4-gated cells. Cognate pairs of linear IgH and IgL genes were
cotransfected into 293FT cells, and the concentration of antibodies in the cell culture supernatant was determined (upper). The antigen
specificity of the mAbs was expressed as relative light units (RLU)/IgG (lower).
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Figure 5 Isolation of rat antigen-specific plasma/plasmablast cells (ASPCs) using fluorescence-activated cell sorting (FACS). (A) A
representative FACS graph of the lymphocytes from green fluorescent protein (GFP)-immunized rats stained with anti-rat IgG Dylight 650, ER-
tracker and GFP-Dylight 488. The forward-versus-side-scatter (FSC vs SSC) with gate R1 represents lymphocytes. Plasma/plasmablast cell (PCs)
were gated as IgGlow endoplasmic reticulum (ER)high (R2). The R2-gated cells were further subdivided into the ASPCs (IgGlow ERhigh GFP+, R3
gate) and non-specific PCs (IgGlow ERhigh GFP-, R4 gate). The numbers indicate the mean percentages of cells in the gated area from three
separate experiments. (B) The R3-gated and R4-gated cells stained intracellularly with anti-rat IgG Dylight 594 (red) and GFP Dylight 488 (green).
The numbers indicate the mean percentages of cells with IgG and GFP signals from three separate experiments. (C) Representative agarose gel
electrophoresis of cognate pairs of V genes amplified from single-cell-sorted R3-gated and R4-gated cells. (D) Antigen specificity of the rat
monoclonal antibodies (mAbs) produced from R3-gated and R4-gated cells. Cognate pairs of linear IgH and IgL genes were cotransfected into
293FT cells. The antigen specificity of the mAbs was expressed as relative light units (RLU)/IgG.
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on their reactivity with GFP as either IgGlow ERhigh GFP+
cells (R3) or IgGlow ERhigh GFP- cells (R4). Our immuno-
fluorescence analysis of the R3-gated cells demonstrated
that 76% of the cells reacted with GFP, whereas only 2% of
the R4-gated cells reacted with GFP. Although both rab-
bits and rats received the same GFP as the immunogen,
rats had higher PC fraction than that of rabbits (2.56% ver-
sus 0.09%). This is probably due to the differences in anti-
gen recognition between the two animals. Amplification of
cognate pairs of VH and VL genes followed by DNA
transfection of pairs of linear IgH and IgL genes into
293FT cells resulted in the highly efficient production of
GFP-specific antibodies by the R3-gated cells but not by
the R4-gated cells. These results clearly demonstrate that
ERIAA provides a powerful method to identify and collect
ASPCs from a variety of animals in a rapid one-step
process.
Production of guinea pig mAbs against human insulin
Because antibodies in animals are produced by their
immune systems, a strong antibody response to a given
antigen occurs when there is a wide phylogenetic dis-
tance between the immunized animal and the species
providing the antigen. Mature human insulin differs
from guinea pig insulin at 18 of 51 amino acids but dif-
fers from rat and mice insulin at only 4 residues. There-
fore, guinea pigs produce high-affinity antibodies against
human insulin. Because the introduction of guinea pig
mAbs in insulin immunoassays may reduce the amount
of undesirable variables caused by the use of polyclonal
antibodies, we sought to generate a guinea pig mAb
against human insulin. Lymphocytes from human insu-
lin-immunized guinea pigs were stained with anti-guinea
pig IgG Dylight 488, ER-tracker and insulin-Cy3, and
the insulin-specific PCs were gated as IgGlow ERhigh
insulin+ (R3 gate) (Figure 6A). A high amplification suc-
cess rate for cognate pairs of VH, VL and/or VLl genes
from the single-cell-sorted R3-gated cells was achieved
(89%, 126 of 142) (Figure 6B,C). DNA transfection of
pairs of the linear IgH and IgL genes into 293FT cells
resulted in the highly efficient production of recombi-
nant guinea pig mAbs against human insulin (Figure
6D). When eight of the highly binding clones were
selected for large-scale expression and their dissociation
constants were analyzed, they demonstrated high affi-
nities (Kd = 0.85 to 8.6 nM) (Figure 6E and Additional
file 1). DNA sequencing of these clones revealed that
the mAbs were divided into three phylogenetic clusters
(Additional file 2). Western blot and peptide competi-
tion analyses revealed that clones clustered in group 1
(a32, c08 and c68) were directed to an epitope that
includes residues B20-30. Clones clustered in group 3
(a43, b56, b66 and c56) react with the C-terminal of the
B chain; however, their binding was partially inhibited
by B1-20. Clone 21 in group 2 also reacted with the C-
terminal of B chain, but its binding was neither inhib-
ited by B1-20 nor B20-30 (Additional file 3). An immu-
nohistochemical analysis of paraffin-embedded mouse
pancreatic sections showed the staining of b cells by the
guinea pig mAb c08 against human insulin (Figure 6F).
Discussion
The use of ASPCs is best suited to the generation of
high affinity mAbs because somatic hypermutation of
immunoglobulin genes allows a continual improvement
in antibody recognition during the course of PC differ-
entiation. However, the isolation of ASPCs is one of the
most challenging types of cell separation due to the
scarcity of ASPCs in lymph nodes and blood. Recently,
several groups reported a microengraving method for
the selection of ASPCs by using an array of on-chip
micro wells [5,6]. But the microwell-based method suf-
fers from several problems, including the limited appli-
cation of this method for species other than humans
and mice and the limited numbers of cells that can be
analyzed per experiment. FACS, on the other hand,
enables the analysis of large numbers of cells at high
speeds; however, the isolation of ASPCs by FACS had
yet to be established. The main limitation in isolating
ASPCs has been the non-specific binding of cells to
fluorescently labeled antigens, which is caused by the
use multiple antibodies against lineage-specific markers
to enrich for PCs. To overcome these limitations, we
developed ERIAA for detecting ASPCs from a variety of
animals by FACS. Because ERIAA is based on weak cell
surface IgG expression and abundant cytoplasmic rough
ER, common features of PCs across animal species, a
series of antibodies against lineage markers is not
required for PC identification. By simply staining lymph
node cells with antibodies against cell surface IgG and
ER-tracker, we achieved PC identification from humans,
mice, rabbits and rats with 70% to 90% purity, repre-
senting a 48-fold to 223-fold enrichment of PCs com-
pared with the original lymphocyte populations.
Furthermore, the reduction of background noise, due to
not using several lineage-specific markers, allowed us to
isolate ASPCs with a fluorescently labeled antigen.
Unlike hybridoma and antibody display technology,
ERIAA does not require a large number of lymphocytes.
Because of the abundant PCs and small amount of red
blood cells, lymph node is best suited for PCs isolation
by ERIAA. Although the number of PCs in blood is sig-
nificantly lower than that in lymph node, peripheral
blood mononuclear cells can be used as a source in the
case where human monoclonal antibodies from patients
are required. In such a case, the use of ER-tracker in
combination with known PC marker such as CD38 pro-
vides a high yield of PCs with very high purity. The
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Figure 6 Production of guinea pig monoclonal antibodies (mAbs) against human insulin. (A) Representative fluorescence-activated cell
sorting (FACS) graph of human insulin-immunized guinea pig lymphocytes stained with anti-guinea pig IgG, ER-tracker and insulin-Cy3. Gates for
lymphocytes (R1), plasma/plasmablast cells (PCs) (IgGlow endoplasmic reticulum (ER)high, R2) and antigen-specific plasma/plasmablast cells (ASPCs)
(IgGlow ERhigh insulin+, R3) were established. (B) Representative agarose gel electrophoresis of cognate pairs of V genes amplified from single-
cell-sorted R3-gated cells. (C) polymerase chain reaction (PCR) success ratio for the V genes. (D) Antigen specificity of mAbs produced from the
R3-gated cells. (E) Binding affinity and binding epitopes of the highly binding clones in (D). (F) Immunohistochemical staining of insulin with
c08 mAb in (E) (red) and glucagon (green) in a mouse pancreatic section.
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isolation of ASPCs from spleen by ERIAA is less effi-
cient due to the presence of non-plasma cells with
strong ER-tracker signal (unpublished data).
Many protein targets are highly conserved between
mice and humans and can therefore be recognized as self-
antigens by a mouse host, making them less immunogenic.
To avoid this problem of human proteins being recog-
nized as self-antigens in mice, rabbit monoclonal antibody
production by hybridomas was developed [19]. Although a
variety of animals can act as a potential host for producing
mAbs by hybridoma, further application of hybridoma
technologies to animals are expected to be limited due to
difficulties in establishing a partner cell line for fusion. An
alternative method for the generation of monoclonal
antibodies by hybridoma is antibody display, which
bypasses immune tolerance issues with highly conserved
antigens. However, antibodies selected from synthetic
repertoires often resulted in low affinity and/or non-speci-
ficity compared to antibodies derived from immunized
animals. To overcome these limitations, phage antibody
libraries were made from immunized animals and mono-
clonal antibodies with high binding affinity have been
obtained [20-24]. Unlike antibody display technology, our
method enables the preservation of original heavy-light
chain pairings, which is useful in analyzing protective anti-
bodies in infectious disease or identifying autoimmune
antibodies in humans.
Conclusions
Our approach of utilizing ERIAA and high-throughput
cloning enables the rapid generation of antigen-specific
mAbs from a variety of animals. We verified the advantage
of our technology by isolating hundreds of human insulin-
specific mAbs from guinea pigs. Our methods will greatly
contribute to the isolation of high performance mAbs
needed for sensitive diagnostics and therapeutic purposes.
Methods
Materials
Antibodies against rat IgG (unconjugated, Dylight 594
conjugated, Dylight 650 conjugated and alkaline phospha-
tase (AP) conjugated), guinea pig IgG (unconjugated,
Dylight 488 conjugated and AP conjugated), rabbit IgG
(unconjugated, Dylight 594 conjugated, Dylight 650 conju-
gated and AP conjugated) and human IgG (Dylight 488
conjugated) were obtained from Abcam. Anti-mouse
CD45R-PE, anti-mouse CD38-APC, anti-human CD20-PE
and anti-human CD38-APC were obtained from Miltenyi
Biotec (http://www.miltenyibiotec.com/en/default.aspx).
All antibodies were diluted in 1 × phosphate-buffered
saline (PBS) containing 0.5% (w/v) bovine serum albumin
(BSA) and 2 mM ethylenediaminetetraacetic acid (EDTA)
(PBS-BSA). Human insulin was obtained from Roche
Applied Science (http://www.roche-applied-science.com/).
Dynabeads® Oligo-(dT)25 magnetic beads and ER-
Tracker™ Blue-White DPX and primers were purchased
from Life Technologies. DNA sequencing was performed
using an ABI 373XL DNA sequencer (Life Technologies).
The synthetic peptides were purchased from Medical &
Biological Laboratories (https://ruo.mbl.co.jp). Restriction
enzymes and PrimeStar DNA polymerase with 1 × Pri-
meStar GC buffer were obtained from Takara Bio (http://
www.takara-bio.com/). The framework (FW) regions and
complementarity-determining regions (CDRs) were
assigned using IMGT/V-QUEST (http://imgt.cines.fr/
IMGT_vquest/share/textes/).
Cell preparation
Animal experiments were approved by the Committee on
Animal Experimentation at the University of Toyama.
Female ICR mice (6 weeks old), Wistar rats, New Zealand
white rabbits and Hartley guinea pigs were purchased
from Japan SLC, Inc. (http://jslc.co.jp/). Groups of three
animals were used to immunize each antigen. Mice were
immunized three times (at intervals of 3 weeks) subcuta-
neously in the hind footpad with a 50 µl of 50:50 water-in-
oil TiterMax Gold adjuvant emulsion (Sigma-Aldrich,
http://www.sigmaaldrich.com/) containing 25 µg of egg
albumin as an antigen. Rats and rabbits were immunized
four times intramuscularly at the tail base with 200 µl of
50:50 water-in-oil TiterMax Gold adjuvant emulsion
containing 100 µg of GFP. Guinea pigs were immunized
four times intramuscularly at the tail base with a 200 µl of
50:50 water-in-oil TiterMax Gold adjuvant emulsion
containing 100 µg of human insulin. At 1 week after the
final immunization, the iliac or popliteal lymph nodes
were surgically removed and used for the isolation of PCs.
Human experiments were performed with the approval of
the Clinical Research Ethics Committee at the University
of Toyama and Itoigawa General Hospital. We obtained
informed consent from all of the subjects. Human lym-
phocytes were prepared from surgically removed regional
lymph nodes from patients with gallbladder and colon
cancers.
Isolation of ASPCs by ERIAA
Cells (1 to 5 × 106/ml) prepared from mouse or human
lymph nodes were suspended in 1 ml PBS-BSA and
stained with fluorescently labeled antibodies against IgG
for 30 minutes at 4°C with rotation. After washing with
PBS-BSA, the cells were stained with anti-mouse CD45R-
PE and CD38-APC or anti-human CD20-PE and CD38-
APC, respectively. The cells were washed twice with PBS
and incubated with 1 ml PBS containing ER-tracker (1
µM) for 5 minutes at room temperature. The cell suspen-
sion was then diluted with 4 ml PBS and analyzed by
FACS. To achieve single-cell sorting of ASPCs, the cells (1
to 5 × 106/ml) prepared from rabbit, rat or guinea pig
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tissue were suspended in 1 ml PBS-BSA and stained with
fluorescently labeled antigen (0.1 µg/ml) and fluorescently
labeled antibody against IgG at 4°C for 30 minutes with
gentle agitation. After washing with PBS, the cells were
stained with ER-tracker as described above. The forward-
versus-side-scatter (FSC vs SSC) lymphocyte gate (R1) was
applied to exclude dead cells. The PCs (IgGlow ERhigh, R2
gate) were further subdivided into fractions according to
their binding levels of fluorescently labeled antigens to
define the ASPCs (IgGlow ERhigh antigen+) and non-speci-
fic PCs (IgGlow ERhigh antigen-). Single-cell sorting was
performed using a JSAN flow cytometer equipped with an
automatic cell deposition unit (http://baybio.co.jp/english/
top.html) with fluorescently labeled antibodies against IgG
monitored in the FL-l (mouse, human and guinea pig) or
FL-5 (rabbit and rat) channel, fluorescently labeled antigen
in the FL-1 (GFP Dylight 488) or FL-2 (insulin-Cy3) chan-
nel and ER-tracker in the FL-7 channel.
Immunofluorescent analysis
FACS-sorted cells were deposited onto propyltriethoxysi-
lane-coated glass slides (Matsunami Glass, http://www.
m-osaka.com/en/exhibitors/231/), fixed with 4% parafor-
maldehyde and permeabilized with PBS containing 0.1%
Triton X-100. The cells were stained with a fluorescently
labeled antibody against IgG and fluorescently labeled
antigen for 60 minutes at room temperature. The images
were captured using an Olympus IX71 fluorescence
microscope equipped with a SPOT RT3 digital micro-
scopy camera (SPOT Imaging Solutions, http://www.
spotimaging.com/) and compiled using Adobe Photoshop
CS5 software. A minimum of 100 cells were counted for
analysis in each experiment, and each experiment was
performed in triplicate.
Plasmid construction
DNA fragments encoding the human, rabbit, rat and
guinea pig immunoglobulin gamma (IgG), kappa (IgK)
and lambda (Igl) constant regions were amplified using
lymphocyte cDNAs as the templates with primers for
IgG (IgGC S and IgGC AS), IgK (IgKC S and IgKC AS)
and Igl (IglC S and IglC AS), respectively. The ampli-
fied DNA fragments digested with XhoI and NotI were
inserted into the corresponding sites of pJON-IgG [14].
The DNA fragments encoding the human insulin A and
B chains were subcloned into the SpeI/XhoI site of the
pET42b vector. The human insulin B chain mutants B1-
13 and B1-20 were generated using the QuikChange XL
Site-Directed Mutagenesis Kit (Agilent Technologies;
http://www.genomics.agilent.com/) with wild-type
human insulin B chain DNA as the template. The pri-
mers used were as follows: B(1-13) forward 5’-
TGCGGCTCACACCTGGTGGAAAAACTTGCGGC
CGCACTCGAG-3’, B1-13 reverse 5’-CTCGAGTGCG
GCCGCAAGTTTTTCCACCAGGTGTGAGCCGCA-3’,
B1-20 forward 5’-GCT CTCTACCTAGTGTGCGG-
GAAACTTGCGGCCGCACTCGAG-3’ and B1-20 reverse
5’-CTCGAGTGCGGCCGCAAGTTTCCCGCACACT
AGGTAGAGAGC-3’. Insulin epitope-glutathione S-trans-
ferase (GST) fusion proteins were produced in Escherichia
coli BL21 (DE3) and purified using Superflow Ni-NTA
columns (Qiagen, http://www.qiagen.com/default.aspx).
The antigens were labeled with DyLight Fluor Labeling
Reagents (Thermo Scientific, http://www.thermoscientific.
com/) and purified using Bio-Gel columns (BIO-RAD,
http://www.bio-rad.com/).
Molecular cloning of VH and VL genes from single cells
VH and VL genes were amplified from sorted single cells as
previously described, with some modifications [14]. Single
cells were sorted into each well of U-bottom 96-well plates
containing 10 µl cell lysis/binding solution (100 mM Tris
HCl (pH 7.5), 500 mM LiCl, 1% lithium dodecyl sulfate, 5
mM dithiothreitol and 10 µg oligo-(dT)25 magnetic beads).
Preparation of the 3’-end homopolymer-tailed cDNA from
single ASPCs is performed automatically by a non-contact
magnetic power transmission instrument (MAGrahd) [13].
The VH and VL genes were amplified by 5’ RACE PCR
using the 3’-end homopolymer-tailed cDNA fragments as
the templates. Briefly, the first round of PCR was per-
formed with a forward primer (Nhe polyC S) and a mix-
ture of reverse primers (IgGV AS1, IgKV AS1 and IglV
AS1). PCR was performed using PrimeStar DNA polymer-
ase in 1 × PrimeStar GC buffer with the BIO-RAD MyCy-
cler (35 cycles with denaturation at 95°C for 30 s,
annealing and strand elongation at 68°C for 90 s and a
final extension at 72°C for 180 s. The resulting PCR mix-
tures were diluted 1:10 with water and 1 μl of each was
used for the second round of PCR. The second round of
PCR was performed with a forward primer (Nhe-Eco47)
and a respective nested reverse primer (IgGV AS2, IgKV
AS2 or IglV AS2) as described above. The primers used
are summarized in Table 1.
TS-jPCR
TS-jPCR was performed as previously described [14]. The
IgH and IgL DNA cassettes were amplified from the
respective pJON plasmids using PCR with primers for IgG
(IgH cassette S and Cassette AS), IgK (IgLk cassette S and
Cassette AS) and Igl (IgLl cassette S and Cassette AS).
The amplified DNA cassettes were purified using S-400
spin columns. The PCR-amplified V gene fragments were
joined to their respective DNA cassettes to build linear
IgH and IgL genes by TS-jPCR. The primers used were
Joint S and Joint AS. The PCR primers are detailed in
Table 1.
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Table 1 Primers used in this study
Name Sequence Application
human IgGV AS1 ACGCTGCTGAGGGAGTAGAGTCCTGAG 5’ RACE PCR human VH first
human IgGV AS2 AGCCGGGAAGGTGTGCACGCCGCTG 5’ RACE PCR human VH second
human IgKV AS1 CTTTGGCCTCTCTGGGATAGAAGTT 5’ RACE PCR human VL first
human IgKV AS2 ACAACAGAGGCAGTTCCAGATTTCAACTGC 5’ RACE PCR human VL second
human IglV AS1 TCACDGSYCCCGGGTAGAAGTCACT 5’ RACE PCR human VLl first
human IglV AS2 AGTGTGGCCTTGTTGGCTTG 5’ RACE PCR human VLl second
rat IgGC S AGAGACTCGAGTGGAACTCTGGAGCCCTGTCCAGCG Rat IgG constant gene cloning
rat IgGC AS CTCTCTGCGGCCGCGGGTCATTTACCCGGAGAGTGGGAGAG Rat IgG constant gene cloning
rat IgKC S AGAGACTCGAGGGGCTGATGCTGCACCAACTGTATC Rat IgK constant gene cloning
rat IgKC AS CTCTCTGCGGCCGCGTCTAACACTCATTCCTGTTGAAGCTC Rat IgK constant gene cloning
rat IgGV AS1 GCAGGTGACGGTCTGGCTGGRCCAGGTGCTGGA 5’ RACE PCR rat VH first PCR
rat IgGV AS2 CTGCAGGACAGCTGGGAAGGTGTGCAC 5’ RACE PCR rat VH second PCR
rat IgKV AS1 TAACTGTTCCGTGGATGGTGGGAAGAT 5’ RACE PCR rat VL first PCR
rat IgKV AS2 TCGTTCAGTGCCATCAATCTTCCACTTGAC 5’ RACE PCR rat VL second PCR
rat IgH cassette S TGGAACTCTGGAGCCCTGTCCAGCGGTG Rat IgH cassette amplification
rat IgLk cassette S GGGCTGATGCTGCACCAACTGTATC Rat IgLk cassette amplification
rab IgGC S AGAGAGCTCGAGTGCCTGGTCAAAGGCTACCTCCCG Rabbit IgG constant gene cloning
rab IgGC AS GTGTGTGCGGCCGCGCTCATTTACCCGGAGAGCGGGAGAT Rabbit IgG constant gene cloning
rab IgKC S AGAGAGCTCGAGGATCCAGTTGCACCTACTGTCCTCA Rabbit IgK constant gene cloning
rab IgKC AS AGAGAGGCGGCCGCTCTAGCAGTCACCCCTGTTGAAGCT Rabbit IgK constant gene cloning
rab IgGV AS1 GCTGGCTGCTTGAGGTCACGCTCACCAC 5’ RACE PCR rabbit VH first PCR
rab IgGV AS2 CTGCCGGACGGACGGGAAGGTGCGTAC 5’ RACE PCR rabbit VH second PCR
rab IgKV AS1 CAGTTGTTTGGGTGGTGCCATCCAC 5’ RACE PCR rabbit VL first PCR
rab IgKV AS2 GGGTGGTGCCATCCACCTCCCAGGTGAC 5’ RACE PCR rabbit VL second PCR
rab IgH cassette S CCAGTTGCACCTACTGTCCTCATCTTCC Rabbit IgH cassette amplification
rab IgLk cassette S GATCCAGTTGCACCTWCTGTCCTCMTCTTCC Rabbit IgLk cassette amplification
g-pig IgGC S AGAGACTCGAGTGCCTGGTCAAGGGCTACTTCCCTGA Guinea pig IgG constant gene cloning
g-pig IgGC AS2 ATCTCCCGGTCTCCGGGTAAATGAGCGGCCGCTCTCTC Guinea pig IgG constant gene cloning
g-pig IgKC S AGAGACTCGAGGGGACCAAGCTGGAAATCAAACGGA Guinea pig IgK constant gene cloning
g-pig IgKC AS TATATAGCGGCCGCCTAGCACTCGCTCCTGTTGATGGTCT Guinea pig IgK constant gene cloning
g-pig IglC S AGAGACTCGAGTGCCTGGTCAAGGGCTACTTCCCTGA Guinea pig Igl constant gene cloning
g-pig IglC AS GAGAGAGCGGCCGCTCATTTACCCGGAGACCGGGAGAT Guinea pig Igl constant gene cloning
g-pig IgGV AS1 CTTGTCCACCTTGGTGCTGCTGGCCGGGTG 5’ RACE PCR guinea pig VH first
g-pig IgGV AS2 GACTGAAGGACGGCCGGGAAGGTGTGCAC 5’ RACE PCR guinea pig VH second
g-pig IgKV AS1 CAGAGCCATCCACCTTCCACTTGACGG 5’ RACE PCR guinea pig VL first
g-pig IgKV AS2 GAAGAGGGAGATAGTTGGCTTCTGCACACT 5’ RACE PCR guinea pig VL second
g-pig IglV AS1 CTGCTGGCCATGTATTTGTTGTCGCTCTG 5’ RACE PCR guinea pig VLl first
g-pig IglV AS2 AGAAGGAATTCAGGAGACACACCACTGT 5’ RACE PCR guinea pig VLl second
g-pig IgH cassette S TGCCTGGTCAAGGGCTACTTCCCTGAGC Guinea pig IgH cassette amplification
g-pig IgLk cassette S GGGACCAAGCTGGAAATCAAACGGAG Guinea pig IgLk cassette amplification
g-pig IgLl cassette S GAGGAGCTCCAGGACAACAAGGCCAC Guinea pig IgLl cassette amplification
Nhe polyC S GCTAGCGCTACCGGACTCAGATCCCCCCCCCCCCCDN 5’ RACE PCR first
Nhe-Eco47 CGCTAGCGCTACCGGACTCAGATCCC 5’ RACE PCR second
Cassette AS GGGGGGGGGGGGGATCTGAGTC Cassette amplification
Joint S AGAGAAACCGTCTATCAGGGCGATGGC TS-jPCR
Joint AS AGAGACCCTTTGACGTTGGAGTCCACG TS-jPCR
PCR = polymerase chain reaction; RACE = rapid amplification of cDNA ends; TS-jPCR = target-selective joint PCR.
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DNA transfection
The cognate pairs of IgH and IgL genes produced by
TS-jPCR were cotransfected using the FuGENE HD
Transfection Reagent (Roche, http://www.roche.com/
research_and_development.htm) into 293FT cells grown
in 96-well culture dishes. At 3 days after transfection,
the cell culture supernatants were analyzed for the
secretion of recombinant antibodies. The antibody con-
centrations and reactivities were determined by enzyme-
linked immunosorbent assay (ELISA), as described pre-
viously [13]. Large-scale recombinant mAbs were pre-
pared using the FreeStyle™ 293 Expression System (Life
Technologies) according to the manufacturer’s protocol.
The antibodies produced were purified using HiTrap™
Protein A HP columns (GE Healthcare, http://www3.
gehealthcare.com/en/Global_Gateway). The protein con-
centrations were determined spectrophotometrically at
280 nm. The integrity of the produced antibodies was
verified using SDS-PAGE with an IgG as the reference.
Affinity measurement
The wells of an ELISA plate were coated overnight with
50 μl of 50 nM human insulin in 100 mM bicarbonate
buffer and blocked with PBS-BSA for 1 h at room tem-
perature. Human insulin (0, 20, 50, 100, 150 and 200
nM) was incubated in PBS with guinea pig mAbs or
control IgG (0.5 and 1 nM) overnight at room tempera-
ture to reach equilibrium. The antibody mixtures were
then transferred to the insulin-coated wells and incu-
bated for 1 h at room temperature. After washing the
plate with PBS, the bound guinea pig mAbs were
detected with AP-conjugated goat anti-guinea pig IgG.
The developed chemiluminescence was quantified using
a Tecan GENios microplate reader (TECAN, http://
www.tecan.com). The magnitude of light emitted was
expressed as relative light units (RLU). Each sample was
tested in duplicate. The dissociation constant (Kd) of the
antigen-antibody complexes was determined according
to the following equation:
Ao/Ao− Ai = 1 + Kd/ao
where Ao and Ai are the signal of total antibody incu-
bated in the absence and presence of a given concentra-
tion of antigen, respectively, and ao is the total
concentration of antigen in the antigen-antibody mixture.
Epitope mapping
Mapping of the antibody epitopes was performed using
competitive ELISA. Briefly, epitope-GST fusion proteins
(100 nM) and a series of peptides (250 nM) was incu-
bated in PBS with the guinea pig mAbs (1 nM) over-
night at 4°C. The peptide/antibody mixture was then
transferred to an insulin-coated plate and tested for
reactivity against insulin, as described above. The anti-
body epitopes were also determined by western blot
analysis using bacterially expressed GST-fused insulin A
chain, B chain and B chain truncation mutants (1-20
and 1-13). The peptides used corresponded to amino
acid residues 1 to 10, 6 to 15 and 12 to 21 of the A
chain and 1 to 10, 6 to 15, 11 to 20, 16 to 25 and 20 to
30 of the B chain of human insulin.
Immunohistochemistry
Formalin-fixed, paraffin-embedded mouse pancreatic tis-
sue samples were subjected to double immunohisto-
chemical staining for insulin and glucagon. The primary
antibodies used were a rabbit monoclonal anti-human
glucagon antibody (Cell Signaling Technology, http://
www.cellsignal.com/) to identify a cells and guinea pig
monoclonal anti-human insulin antibodies to identify b
cells. The insulin signal was visualized with goat anti-
guinea pig antibody-AP and the VECTOR Red Alkaline
Phosphatase Substrate Kit (Vector Labs, http://www.vec-
torlabs.com/). The glucagon signal was visualized with
goat anti-rabbit IgG Dylight 488. The tissue samples
were embedded in ProLong Gold Antifade Reagent with
4’,6-diamidino-2-phenylindole (DAPI; Life Technolo-
gies), subjected to fluorescence microscopy and analyzed
using 2D Deconvolution MetaMorph software (Molecu-
lar Devices, http://www.moleculardevices.com/).
Additional material
Additional file 1: Klotz plots. Klotz plots of the binding of human
insulin to guinea pig monoclonal antibodies (mAbs), as measured using
ELISA. a0, the concentration of total antigen; A0, the chemiluminescence
measured for the antibody in the absence of antigen; Ai, the
chemiluminescence measured for bound antibody. The value in the
parentheses represents the average of the different guinea pig mAb
concentrations (0.5 nM and 1.0 nM).
Additional file 2: Phylogenetic analysis of VH and VL amino acid
sequences of the highly binding guinea pig monoclonal antibodies
(mAbs). (A) Guinea pig mAbs of the same lineage group are boxed and
labeled as 1, 2 or 3. (B) Sequences of the corresponding VH and VL
amino acid regions of the highly binding guinea pig mAbs.
Additional file 3: Epitope mapping of the highly binding guinea pig
monoclonal antibodies (mAbs). (A) Western blots of epitope-
glutathione S-transferase (GST) fusion proteins with guinea pig mAbs.
About 0.1 μg of proteins were loaded on 15% SDS-PAGE. Lane 1: GST;
lane 2: GST-insulin A; lane 3: GST-insulin B; lane 4: GST-insulin B1-20; lane
5: GST-insulin B1-13. (B) Epitope mapping by competitive enzyme-linked
immunosorbent assay (ELISA). Excess amount of epitope-GST fusion
proteins (10-fold molar excess relative to mAb) or overlapping peptides
of human insulin (25-fold molar excess) were used as competitors.
Binding of the antibodies to wild-type human insulin without
competitors was set as 100%. Each experiment was repeated
independently twice, and the mean values are shown.
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